Active, not recruitingPhase 3NCT04923893
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
Studying Infantile neuroaxonal dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Janssen Research & Development, LLC
- Principal Investigator
- Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC
- Intervention
- Bortezomib(drug)
- Enrollment
- 743 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2036
Study locations (30)
- UCSF, San Francisco, California, United States
- Yale Cancer Center, New Haven, Connecticut, United States
- University of Miami Health System, Miami, Florida, United States
- AdventHealth Cancer Institute, Orlando, Florida, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- University of Kentucky, Lexington, Kentucky, United States
- Norton Cancer Institute, Louisville, Kentucky, United States
- University Of Maryland Medical Center, Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
- Henry Ford Cancer Institute, Detroit, Michigan, United States
- Columbia University Medical Center, New York, New York, United States
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
- New York Presbyterian-Weill Cornell Medical College, New York, New York, United States
- Levine Cancer Institute, Charlotte, North Carolina, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04923893 on ClinicalTrials.govOther trials for Infantile neuroaxonal dystrophy
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06964412The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate BrachytherapyBrigham and Women's Hospital
- RECRUITINGNANCT07267468Effectiveness of an mHealth Intervention, Based on Rehabilitation and a Personalised Nutrition Plan, in the Recovery and Improvement of Dysphagia in Patients Diagnosed With StrokeUniversity of Cadiz
- RECRUITINGNANCT07411300Supporting Caregivers Following Mental Health Emergency Department VisitsAnn & Robert H Lurie Children's Hospital of Chicago
- RECRUITINGNANCT07315607In Vivo Evaluation of the Accuracy of Immediate Screw-Retained Provisional Crowns Fabricated Using Digital Planning and Guided SurgeryUniversidad Complutense de Madrid
- RECRUITINGPHASE2NCT07361120Plan A Occlusion and Reversal System Feasibility StudyNext Life Sciences
- ENROLLING BY INVITATIONNANCT07294573Maternal Health Assessment in Pediatric CareJohn James Parker
- RECRUITINGNANCT07329452Menu to Meal (M2M) Menu Labeling Intervention StudyTexas A&M University
- RECRUITINGNANCT07472296Comparison of Erector Spinae Plane Block (ESPB) With the Combination of Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) in the Management of Postoperative Sternotomy Pain in Patients Undergoing Cardiac Surgery Via SternotomyUludag University